The development of A [211At]-astatinated endoradiotherapeutic drug: Part I. Localization by alpha-particle autoradiography in a murine tumor model.
Alpha-particle track autoradiography has been used to define the in vivo cellular and intracellular distribution of radioactivity from the potential high linear energy transfer endoradiotherapeutic drug, 6-[211At]-astato-2-methyl-1,4-naphthoquinol bis(diphosphate) in tumor and relevant critical normal tissues of mice bearing a transplanted murine rectal carcinoma. A strikingly selective uptake of this compound into tumor cells, particularly into specific tumor cell nuclei, has been demonstrated. Its localization in certain tumor cells appears to depend on the presence of an onco-product, in this case an alkaline phosphatase isoenzyme, which is synthesized in some tumor cells and to which the compound targets. In curable tumors, it selectively concentrates in cells which may be regarded as tumor stem cells. There is low uptake into normal cells, particularly those in bone marrow, colon, and lung, where its sequestration is mainly extranuclear.
Brown
I
I
Research Laboratories, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, UK.
Carpenter
R N
RN
Mitchell
J S
JS
D000469:Alkaline Phosphatase / Q000032:analysis; D000512:Alpha Particles; D000818:Animals; D001246:Astatine / Q000378:metabolism / Q000627:therapeutic use*; D001345:Autoradiography; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D012004:Rectal Neoplasms / Q000098:blood supply / Q000532:radiotherapy*
D000469:Alkaline Phosphatase; D001246:Astatine